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Abstract Hsp40 proteins of bacterial and human origin are
suspected to be involved in the pathogenesis of rheumatoid
arthritis (RA). It has been shown that sera of RA patients
contain increased levels of antibodies directed to bacterial
and human Hsp40s. The aim of this work was to explore
immunological similarities between the bacterial (DnaJ) and
human (DNAJA1 and DNAJA2) Hsp40 proteins in relation
to their possible involvement in the RA. Using polyclonal
antibodies directed against a full-length DnaJ or its domains,
against DNAJA1 and DNAJA2, as well as monoclonal anti-
DnaJ antibodies, we found immunological similarities be-
tween the bacterial and human Hsp40s. Both ELISA and
Western blotting showed that these similarities were not
restricted to the conserved J domains but were also present
in the C-terminal variable regions. We also found a positive
correlation between the levels of the anti-DnaJ and anti-
DNAJA1 antibodies in the sera of RA patients. This finding
supports the molecular mimicry hypothesis that human
Hsp40 could be the targets of antibodies originally directed
against bacterial DnaJ in RA.
Keywords Anti-Hsp40 autoantibodies . Hsp40 in
rheumatoid arthritis . Cross-reactivity of anti-Hsp40
antibodies . Anti-DNAJmonoclonal antibodies . Molecular
mimicry
Introduction
Heat shock proteins (Hsps) are a family of evolutionarily
conserved proteins, which play an important role in cell phys-
iology under the normal and stress conditions. At times of
cellular stress, including infection and chronic inflammation,
such as present in autoimmune diseases, the expression of
Hsps is markedly elevated (reviewed in van Eden et al. 2005;
Borges et al. 2012). Hsps are also a group of major bacterial
antigens (Albani et al. 1995; reviewed in Borges et al. 2012),
and the conservation of their structure from bacteria to man, as
well as high immunogenicity, makes them attractive targets
for investigation in the area of autoimmunity. In this area, the
Hsps of the Hsp60 and Hsp70 families were the ones most
extensively studied, especially since the discovery that the T
cells isolated from the rats with adjuvant-induced arthritis
were responding to mycobacterial Hsp60 (van Eden et al.
1988; reviewed in van Eden et al. 2005). To the contrary, the
research on Hsp40 involvement in autoimmune diseases has
been less extensive, in spite of the fact that Hsp40 is probably
the largest Hsp family in humans, with at least 50 members
(reviewed in Kampinga et al. 2009).
The model representative of the Hsp40 family is the
Escherichia coli DnaJ protein, composed of 375 amino
acids in four domains. The amino-terminal 75 residues of
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DnaJ constitute an evolutionarily highly conserved motif, the
J domain, which together with the adjacent region, rich in
glycine and phenylalanine, is essential for DnaJ’s interactions
with Hsp70 chaperone. The third domain, rich in cysteine
residues, together with the least conserved C-terminal region,
functions to bind substrate proteins (Qiu et al. 2006; reviewed
in Kampinga et al. 2009). Of human Hsp40, the DNAJB1
(Hdj1), DNAJA1 (Hdj2), and DNAJA2 (Hdj3) proteins are
best characterized (Terada and Mori 2000; reviewed by
Sterrenberg et al. 2011). DNAJA1 and DNAJA2, belonging to
the class A of Hsp40, bear the highest structural similarity to
the bacterial DnaJ and possess all the domains characteristic
for DnaJ, while DNAJB1 does not have the cysteine-rich
domain (Cheetham and Caplan 1998; Kampinga et al. 2009).
Bacterial and human Hsp40 are suspected to participate
in the autoimmune response during pathogenesis of rheu-
matoid arthritis (RA) and juvenile idiopathic arthritis (JIA).
The presence of elevated levels of antibodies against the E.
coli DnaJ has been shown in RA (Albani et al. 1994, 1995;
Chukwuocha et al. 1999; Tukaj et al. 2010a), with especially
high response to the conserved J domain of DnaJ (Albani et
al. 1995; Tukaj et al. 2010a). Additionally, an overexpres-
sion of human Hsp40s and significantly increased levels of
the anti-DNAJA1 and anti-DNAJA2 antibodies have been
found, respectively, in the synovial tissue and sera of RA
patients (Kurzik-Dumke et al. 1999; Tukaj et al. 2010a).
Initially, a “molecular mimicry hypothesis” has been pro-
posed, suggesting that the immune response directed against
the bacterial DnaJ protein cross-reacts with the human ho-
mologous protein(s) and promotes development of RA; an
infection with various bacterial species could trigger the
response, since DnaJ is highly conserved among bacteria
(Albani et al. 1995; Albani and Carson 1996). Indeed,
bacterial infection is considered as one of the possible
factors promoting development of RA (reviewed in Lundberg
et al. 2010). Later on, another aspect of the Hsp40s role in
inflammatory diseases emerged, showing an immunomodula-
tory role of Hsp40s in downregulating immune response. It
has been demonstrated that T cells from patients with JIA
respond differentially to peptides derived from bacterial and
human Hsp40s and that regulatory T cells, induced by a
peptide derived from a human Hsp40, downregulate prolifer-
ation of synovial fluid mononuclear cells of JIA patients
(Massa et al. 2007). Our previous study showed that DnaJ
and human Hsp40 proteins inhibited proliferation of T cells of
the RA patients and had an immunomodulatory effect on
cytokine secretion by the patients’ lymphocytes (Tukaj et al.
2010a). Although the exact role of bacterial and human
Hsp40s in the autoimmune response requires further elucida-
tion, it is clear that those proteins have a relevance in the
clinical setting, especially since Hsp40s are considered as
potential targets for anti-inflammatory therapy in JIA (Massa
et al. 2007) and RA (Tukaj et al. 2010a).
Previously, we have shown a significant immunological
similarity between bacterial DnaJ and human DNAJB1, not
restricted to the conserved J domains of the proteins
(Krzewski et al. 2003). The aim of this work was to further
investigate the immunological similarities among the bacte-
rial and human Hsp40s and focus on the DNAJA1 and
DNAJA2, the human Hsp40s best structurally matched with
DnaJ. We tested cross-reactivity of the bacterial and human
Hsp40s with the monoclonal antibodies, recognizing differ-
ent and defined DnaJ epitopes, and with polyclonal anti-
bodies against full-length DnaJ, DnaJ N-terminal domain
(N-DnaJ), DnaJ C-terminal domain (C-DnaJ), DNAJA1,
and DNAJA2. We also assayed the humoral anti-Hsp40
response in RA patients and analyzed correlation between
the bacterial and human anti-Hsp40 antibody levels.
Results and discussion
Polyclonal antibodies against DnaJ, N-DnaJ, and C-DnaJ
react with human DNAJA1 and DNAJA2
We purified recombinant bacterial (E. coli DnaJ, N-DnaJ,
C-DnaJ) and human (DNAJA1 and DNAJA2) Hsp40 pro-
teins, overproduced in bacterial cells (Fig. 1a), and used them
as antigens to obtain rabbit polyclonal antibodies. Cross-
reactivity of these antibodies with the Hsp40 proteins was
tested by Western blotting technique and ELISA tests.
The immunoblotting results showed that the anti-DnaJ
antibodies were able to cross-react with both DNAJA1 and
DNAJA2 (Fig. 1b). The anti-N-DnaJ antibodies reacted
with DNAJA2 but not with DNAJA1 (Fig. 1c). Conversely,
the anti-C-DnaJ antibodies reacted with DNAJA1 but not
with DNAJA2 (Fig. 1d). These results indicate immunolog-
ical similarity between DnaJ, and human DNAJA1 and
DNAJA2, with DNAJA1 bearing a higher similarity to the
C-terminal part of DnaJ and DNAJA2 to the N-terminal
domain. This conclusion was confirmed further by the fact
that the anti-DNAJA1 serum reacted strongly with C-DnaJ
protein and weakly with N-DnaJ (Fig. 1e), while the anti-
DNAJA2 antibodies reacted well with N-DnaJ but very
weakly with C-DnaJ (Fig. 1f). The identity at the amino
acid level between DnaJ and DNAJA1 or DNAJA2 is 38 or
39 %, respectively. Surprisingly, we noticed a very weak
reaction of anti-DNAJA1 serum with DNAJA2 in spite of
54 % identity at the amino acid level between DNAJA1 and
DNAJA2 (Fig. 1e). In parallel, the anti-DNAJA2 antibodies
reacted very weakly or not at all with DNAJA1 (Fig. 1f and
results not shown). The latter finding is in agreement with
the results of Terada and Mori (2000), who showed the lack
of cross-reactivity of the anti-Hdj3 (DNAJA2) antibodies
with Hdj2 (DNAJA1) in immunoblotting. This also shows
that the degrees of sequence identity and immunological
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similarity may differ. It should be noted that the anti-
DNAJA1 serum recognized the full-length DnaJ (Fig. 1e).
The results obtained by the Western blotting technique, in
which only linear epitopes were recognized, were confirmed
by the ELISA tests in which non-denatured antigens were
used. The anti-DnaJ antibodies cross-reacted with both
DNAJA1 and DNAJA2 (Fig. 2a). The anti-N-DnaJ anti-
bodies reacted well with both DNAJA1 and DNAJA2
(Fig. 2b), while in the immunoblots, the reaction with
DNAJA1 was almost non-detectable. The reason why we
could observe the reaction with DNAJA1 here but not in the
immunoblots could be due to the presence of the native
antigens and thus of conformational epitopes and/or the
higher sensitivity of the ELISA test compared to Western
blotting. It should be noted that the J domains of DnaJ and
DNAJA1 or DNAJA2 bear about 50 % identity (as calcu-
lated for the residues 1–77, 3–78, and 5–80 of DnaJ,
DNAJA1, and DnaAJA2, respectively). In the case of anti-
C-DnaJ antibodies, a cross-reaction with DNAJA1 and a
minimal binding to DNAJA2 was observed (Fig. 2c), which
was consistent with the immunoblotting results. Like in
immunoblotting, anti-DNAJA1 and anti-DNAJA2 showed
Fig. 1 Cross-reactions between
anti-DNAJ(Hsp40) polyclonal
antibodies and DNAJ(Hsp40)
proteins tested by Western




were overproduced in E. coli
cells, purified, and resolved by
SDS-PAGE. Of each Hsp40
protein, 2.5 μg has been loaded
onto the gel (a). The polyclonal
antibodies indicated above the
panels were used in Western
blotting as the primary
antibodies (b–f)
Fig. 2 Cross-reactions between anti-DNAJ(Hsp40) polyclonal anti-
bodies and DNAJ(Hsp40) proteins tested by ELISA. The reactivity
of polyclonal anti-DnaJ (a), anti-N-DnaJ (b), anti-C-DnaJ (c), anti-
DNAJA1 (d), and anti-DNAJA2 (e) with purified non-denatured
DNAJ antigens was tested as described in “Materials and methods.”
Data obtained for the antigens at 40 μg per milliliter are presented as
the mean±SEM of three independent experiments and expressed as a
percentage of control (i.e., reactivity with the antigen used to raise a
given antibody; indicated as the gray bar)
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very weak cross-reactivity with DNAJA2 and DNAJA1,
respectively (Fig. 2d, e). In ELISA tests, these antibodies
showed poorer reaction with bacterial proteins than in West-
ern blotting. This could be due to inaccessibility of the linear
epitopes which could be exposed only after a denaturation
process takes place during SDS-PAGE in Western blotting
experiments.
Taken together, all the above results show a significant
immunological similarity between DnaJ and DNAJA1/D-
NAJA2 proteins, which in the case of DNAJA1 was found
not only in the conserved J domain but also in the poorly
conserved C-terminal region. Additionally, a very low im-
munological similarity was found between DNAJA1 and
DNAJA2 proteins, suggesting that these antigens induce
different immune responses.
The monoclonal antibodies recognizing DnaJ epitopes react
with DNAJA1 and DNAJA2
To further characterize response of human Hsp40 proteins to
anti-DnaJ antibodies, we used a set of six anti-DnaJ mono-
clonal antibodies (mAbs), whose epitopes have been char-
acterized previously (Krzewski et al. 2003); localization of
these epitopes in DnaJ protein is shown schematically in
Fig. 3a. The mAb AC11 epitope is localized in a highly
conserved region of the J domain while the other epitopes
(BB3, DC7, EE11, CC5, and CC8) are placed in the weakly
conserved C-terminal region. It has been previously shown
(Krzewski et al. 2003) that all these mAbs bind more effi-
ciently to the native DnaJ compared to the denatured protein.
In ELISA tests, the AC11 mAb reacted with both DNAJA1
and DNAJA2 (Fig. 3b). Surprisingly, all the mAbs directed
to the C-terminal region of DnaJ (Fig. 3a) recognized both
human Hsp40s with high efficiency (Fig. 3c–g). These
results indicate that, despite a low identity (not exceeding
20 %) of amino acid sequence among the C-terminal regions
of DnaJ and DNAJA1/DNAJA2, they do have some similar
epitopes (the amino acid residues used to calculate the iden-
tity were 198–373 for DNAJA1 and 206–381 for DNAJA2).
These epitopes are most probably of the conformational
type, since the mAbs used here preferentially bind to the
native DnaJ, and also alignment of the mAbs epitope con-
sensus sequences with the DNAJA1 and DNAJA2 amino
acid sequences did not reveal any putative linear epitopes
(results not shown). These results further confirm that the
anti-DnaJ antibodies can recognize human DNAJA1 and
DNAJA2, and the recognition is not restricted to the con-
served J domains. They also suggest that the C-terminal
domains of DnaJ and DNAJA1/DNAJA2 have a similar
three-dimensional structure. To date, the structures of the
C-terminal, substrate-binding regions of these proteins have
not been solved. Within the Hsp40 family of proteins, the
C-terminal domains of the yeast Sis1 (Sha et al. 2000) and
human Hdj1 (DNAJAB1) protein (Suzuki et al. 2010) have
been crystallized and characterized.
The major conclusion that the anti-DnaJ antibodies can
recognize human DNAJA1 and DNAJA2, and the recogni-
tion is not restricted to the conserved J domain, supports the
“molecular mimicry” hypothesis. This hypothesis states that
in RA, human Hsp40 protein(s) may be the targets of
Fig. 3 Reactivity of anti-DnaJ
monoclonal antibodies (mAbs)
with human DNAJA proteins.
Schematic outline of the DnaJ
linear structure and localization
of the epitopes recognized by
the mAbs are presented in a.
The reactivity of six mAbs
(b–g) with purified
non-denatured DNAJ(Hsp40)
antigens was assayed by ELISA
test as described in “Materials
and methods.” Data obtained
for the antigens at 40 μg per
milliliter are presented as the
mean±SEM of three
independent experiments and
expressed as a percentage of the
reactivity with DnaJ control
(gray bar)
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immune response induced by a bacterial DnaJ antigen
(Albani et al. 1995; Albani and Carson 1996). Our previous
observations that sera derived from RA patients contain
significantly elevated levels of anti-DnaJ, anti-DNAJA1,
and anti-DNAJA2 (but not anti-DNAJB1) antibodies (Tukaj
et al. 2010a, b) are also consistent with the mimicry hypoth-
esis. In this study, using a different set of the RA patient
sera, we obtained similar results (Table S1, Supplementary
data). Furthermore, we found a positive correlation between
the levels of the anti-DnaJ and anti-DNAJA1 antibodies in
the RA sera (Table 1). Since DNAJA1 and DNAJA2 are
modified by farnesylation in humans (Terada and Mori
2000) but not in the bacterial systems, we also purified
and tested the overproduction and farnesylation of these
proteins in the baculovirus eukaryotic expression system.
We did not find any significant differences in the reactivity
of the farnesylated and non-farnesylated proteins with the
RA sera (Table S1, Supplementary data). In the case of the
farnesylated proteins, the positive correlation between the
anti-DnaJ and anti-DNAJA1 responses was also found
(Table 1). The observed correlations indicate that in RA
patients, the anti-DnaJ response may be directed against the
DNAJA1 protein.
The question whether the postulated cross-reaction be-
tween the anti-DnaJ antibodies and human Hsp40s may
lead to pathological consequences remains open. There is
increasing evidence that Hsps may function as factors
downregulating immune response. It has been shown that
the T cells immunoreactive to various types of self-Hsps
display regulatory properties (van Eden et al. 2005;
Wieten et al. 2007, 2010; reviewed in Borges et al. 2012).
The regulatory role of Hsp40s encouraged the idea that they
may be potential targets for designing new anti-inflammatory
therapies (Massa et al. 2007; Tukaj et al. 2010a). Furthermore,
a peptide derived from the J domain of DnaJ has been suc-
cessfully applied in clinical trials of immunotherapy of RA
patients (Koffeman et al. 2009). We believe that the informa-
tion presented in this work increases our understanding of the
anti-Hsp40 immune response and may be useful in designing
new anti-inflammatory therapies.
Materials and methods
Protein overproduction and purification
The DnaJ, N-DnaJ (DnaJΔ107-375), C-DnaJ (DnaJΔ1-
199), DNAJA1, and DNAJA2 recombinant proteins were
overproduced in E. coli cells and purified as described pre-
viously (Krzewski et al. 2003; Tukaj et al. 2010a). To obtain
the DNAJA1 and DNAJA2 proteins modified by farnesyla-
tion, the insect cells (Spodoptera frugiperda Sf9) and bacu-
lovirus expression system Bac-To-Bac (Invitrogen) were
used, according to the manufacturer’s instruction. We con-
structed the pFastBac1/DNAJA1 and pFastBac1/DNAJA2
transfer plasmids, encoding the His6-DNAJA1 and His6-
DNAJA2 proteins, respectively. The plasmid pFastBac1/D-
NAJA1 was derived from the pMal-c2x/hdj2 (Kanazawa et
al. 1997) by excising the Ecl136-XbaI fragment and inserting
it into a pFastBac1 vector. The plasmid pFastBac1/DNAJA2
was constructed by excising the BamHI–PstI fragment of the
pVL1393/hdj3 plasmid (Terada et al. 1997) and inserting it
into a pFastBac1 vector. Other procedures were as described
in the manufacturer’s manual. Farnesylation of His-
DNAJA1/2 proteins was enhanced by exogenously adding
a mevalonate precursor, mevalonolactone (Sigma), to the Sf-
900 II SFM medium, at 5 mM. The His-DNAJA1/2 proteins
produced in insect cells were purified from the cytoplasmic
fraction using a Ni-NTA agarose (Qiagen), according to the
manufacturer’s manual.
Polyclonal and monoclonal antibodies
The polyclonal antisera were raised by immunizing rabbits
with the purified recombinant Hsp40 proteins according to
the method described by Szewczyk and Harper (1994) and
tested by Western blotting with appropriate antigens. The
mouse monoclonal antibodies AC11, BB3, CC8, EE11,
DC7, and CC8 were generated and characterized as de-
scribed by Krzewski et al. (2003).
Table 1 Correlation of the level of the anti-DnaJ antibodies (IgG) with
the levels of the anti-DNAJA1/2 autoantibodies (IgG) in the sera of the
rheumatoid arthritis (RA) patients













The levels of the antibodies were assayed by ELISA test in the sera of
43 RA patients (presented in Table S1, Supplementary data) as de-
scribed in “Materials and methods,” using antigens at the concentra-
tions (in micrograms per milliliter) indicated in parentheses. DNAJA1f
and DNAJA2f are the farnesylated proteins produced in the baculovi-
rus system. The other proteins were produced in the bacterial system.
The correlations between the antibody levels are presented as Pearson’s
coefficients (r). The statistically significant values are shown in italics
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Protein electrophoresis and Western blotting
Hsp40 proteins were resolved in 15 % polyacrylamide gels,
in denaturing conditions. Western blotting was performed,
using the polyclonal rabbit anti-Hsp40 sera as the primary
antibodies and alkaline phosphatase-conjugated goat anti-
rabbit immunoglobulins (Roche) as secondary antibodies, as
described previously (Krzewski et al. 2003). The primary
antibodies were used at the following dilutions: anti-DnaJ
(1:5,000), anti-N-DnaJ (1:200), anti-C-DnaJ (1:500), anti-
DNAJA1 (1:500), and anti-DNAJA2 (1:500), for 1 h at
room temperature. The secondary antibodies were used at
1:200 dilutions.
ELISA assays
ELISA tests were performed as described by Krzewski et al.
(2003), with minor modifications. Costar 3590 96-well
plates were coated with serial dilutions of DnaJ, N-DnaJ,
C-DnaJ, DNAJA1, or DNAJA2 proteins (40–0.02 μg/mL)
and incubated overnight at 37 °C. Then, 50 μL of a diluted
anti-DnaJ mAb was added to the wells. The mAbs were
used at the following dilutions: AC11—1:6,000; BB3, CC8,
and EE11—1:2,000; DC7—1:500; and CC8—1:200. After
60 min of incubation, the secondary antibodies coupled with
horseradish peroxidase (HRP) (Sigma) were added: the goat
anti-mouse IgG antibodies to AC11 and the goat anti-mouse
IgM antibodies to the other mAbs, at 1:2,000 dilutions. The
bound conjugates were detected colorimetrically after
60 min of incubation, by using a horseradish peroxidase
substrate, tetramethylbenzidine (Sigma).
When the reactivity of the Hsp40 proteins with the rabbit
polyclonal anti-Hsp40 sera was tested, the sera were used at
the following dilutions: anti-DnaJ (1:40,000), anti-N-DnaJ
(1:1,000), anti-C-DnaJ (1:4,000), anti-DNAJA1 (1:4,000),
and anti-DNAJA2 (1:4,000). HRP-conjugated goat anti-
rabbit IgG immunoglobulins (Dako) (1:2,000) were used
as secondary antibodies.
The levels of the anti-DnaJ, anti-DNAJ1, and anti-
DNAJ2 antibodies (IgG) in the sera of the RA patients
(n=43) and the control individuals (n=35) were assayed by
the ELISA test performed as described before (Tukaj et al.
2010b). The antigens used were the Hsp40 proteins produced
in the bacterial cells and, additionally, the DNAJA1 and
DNAJA2 produced and farnesylated in the baculovirus sys-
tem (designated as DNAJA1f and DNAJA2f).
The RA patients
The RA patients’ sera were obtained from 43 (29 females
and 14 males) patients (the mean age was 59, range 21–82),
with the early RA (the mean disease duration was 9 months).
For controls, we used sera of 35 sex- and age-matched
healthy volunteers. The study was approved by the Local
Committee for Biomedical Research Ethics at the Medical
University of Gdansk. All subjects were informed of the
details of the experiment prior to the taking of a sample of
10 mL peripheral venous blood.
Statistical analysis
Statistical analyses were performed using the Mann–Whitney
U test and STATISTICA 7.1 software. For correlation analy-
ses, Pearson test was used. p values less than 0.05 were
considered significant.
Acknowledgments We would like to express our thanks to Dr. B.
Szewczyk for his help with overproducing proteins in the baculovirus
system. We are very grateful to Dr. Kazutoyo Terada for his generous
gift of the pMal-c2x/hdj2 and pVL1393/hdj3 plasmids. This work was
supported by a grant from the Polish Ministry of Science and Higher
Education (no. 1610/B/P01/2008/35) to BL.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
Albani S, Carson DA (1996) A multistep molecular mimicry hypoth-
esis for the pathogenesis of rheumatoid arthritis. Immunol Today
17:466–470
Albani S, Ravelli A, Massa M, De Benedetti F, Andree G, Roudier
J, Martini A, Carson DA (1994) Immune responses to the
Escherichia coli dnaJ heat shock protein in juvenile rheuma-
toid arthritis and their correlation with disease activity. J
Pediatr 124:561–565
Albani S, Keystone EC, Nelson JL, Ollier WE, La Cava A, Montemayor
AC, Weber DA, Montecucco C, Martini A, Carson DA (1995)
Positive selection in autoimmunity: abnormal immune responses
to a bacterial dnaJ antigenic determinant in patients with early
rheumatoid arthritis. Nat Med 1:448–452
Borges TJ, Wieten L, van Herwijnen MJ, Broere F, van der Zee R,
Bonorino C, van Eden W (2012) The anti-inflammatory mecha-
nisms of Hsp70. Front Immunol 3:95
Cheetham ME, Caplan AJ (1998) Structure, function and evolution of
DnaJ: conservation and adaptation of chaperone function. Cell
Stress Chaperones 3:28–36
Chukwuocha RU, Zhang B, Lai CJ, Scavulli JF, Albani S, Carson
DA, Chen PP (1999) Isolation of an IgG monoclonal anti-
dnaJ antibody from an immunoglobulin combinatorial library
from a patient with rheumatoid arthritis. J Rheumatol 26:
1439–1445
Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford
EA, Cheetham ME, Chen B, Hightower LE (2009) Guidelines for
the nomenclature of the human heat shock proteins. Cell Stress
Chaperones 14:105–111
Kanazawa M, Terada K, Kato S, Mori M. (1997) HSDJ, a human
homolog of DnaJ, is farnesylated and is involved in protein
import into mitochondria. J Biochem 121:890–895
Koffeman EC, Genovese M, Amox D, Keogh E, Santana E, Matteson
EL, Kavanaugh A, Molitor JA, Schiff MH, Posever JO, Bathon
658 A. Kotlarz et al.
JM, Kivitz AJ, Samodal R, Belardi F, Dennehey C, van den Broek
T, van Wijk F, Zhang X, Zieseniss P, Le T, Prakken BA, Cutter GC,
Albani S (2009) Epitope-specific immunotherapy of rheumatoid
arthritis: clinical responsiveness occurs with immune deviation and
relies on the expression of a cluster of molecules associated with T
cell tolerance in a double-blind, placebo-controlled, pilot phase II
trial. Arthritis Rheum 60:3207–3216
Krzewski K, Kunikowska D, Wysocki J, Kotlarz A, Thompkins P,
Ashraf W, Lindsey N, Picksley S, Głośnicka R, Lipińska B
(2003) Characterization of the anti-DnaJ monoclonal antibod-
ies and their use to compare immunological properties of
DnaJ and its human homologue HDJ-1. Cell Stress Chaperones
8:8–17
Kurzik-Dumke U, Schick C, Rzepka R, Melchers I (1999) Overex-
pression of human homologs of the bacterial DnaJ chaperone in
the synovial tissue of patients with rheumatoid arthritis. Arthritis
Rheum 42:210–220
Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ (2010)
Periodontitis in RA—the citrullinated enolase connection. Nat
Rev Rheumatol 6:727–730
Massa M, Passalia M, Manzoni SM, Campanelli R, Ciardelli L, Yung
GP, Kamphuis S, Pistorio A, Meli V, Sette A, Prakken B, Martini
A, Albani S (2007) Differential recognition of heat-shock protein
dnaJ-derived epitopes by effector and Treg cells leads to modu-
lation of inflammation in juvenile idiopathic arthritis. Arthritis
Rheum 56:1648–1657
Qiu X-B, Shao Y-M, Miao S, Wang L (2006) The diversity of the
DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones.
Cell Mol Life Sci 63:2560–2570
Sha B, Lee S, Cyr DM (2000) The crystal structure of the peptide-
binding fragment from the yeast Hsp40 protein Sis1. Structure
8:799–807
Sterrenberg JN, Blatch GL, Edkins AL (2011) Human DNAJ in cancer
and stem cells. Cancer Lett 312:129–142
Suzuki H, Noguchi S, Arakawa H, Tokida T, Hashimoto M, Satow Y
(2010) Peptide-binding sites as revealed by the crystal structures
of the human Hsp40 Hdj1 C-terminal domain in complex with the
octapeptide from human Hsp70. Biochemistry 49:8577–8584
Szewczyk B, Harper DR (1994) Use of blotted proteins as immuno-
gens. In: Dunbar B (ed) Protein blotting—a practical approach.
IRL Press, Oxford, pp 189–205
Terada K, Mori M (2000) Human DnaJ homologs dj2 and dj3, and bag-1
are positive cochaperones of hsc70. J Biol Chem 275:24728–24734
Terada K, Kanazawa M, Bukau B, Mori M (1997) The human DnaJ
homologue dj2 facilitates mitochondrial protein import and lucif-
erase refolding. J Cell Biol 139:1089–1095
Tukaj S, Kotlarz A, Jozwik A, Smolenska Z, Bryl E, Witkowski JM,
Lipinska B (2010a) Hsp40 proteins modulate humoral and cellu-
lar immune response in rheumatoid arthritis patients. Cell Stress
Chaperones 15:555–566
Tukaj S, Kotlarz A, Jóźwik A, Smoleńska Z, Bryl E, Witkowski JM,
Lipińska B (2010b) Cytokines of the Th1 and Th2 type in sera of
rheumatoid arthritis patients; correlations with anti-Hsp40 immune
response and diagnostic markers. Acta Biochim Pol 57:327–332
van EdenW, Thole JE, van der ZeeR, Noordzij A, van Embden JD,Hensen
EJ, Cohen IR (1988) Cloning of the mycobacterial epitope recognized
by T lymphocytes in adjuvant arthritis. Nature 331:171–173
van Eden W, van der Zee R, Prakken B (2005) Heat-shock proteins
induce T-cell regulation of chronic inflammation. Nat Rev Immu-
nol 5:318–330
Wieten L, Broere F, van der Zee R, Koerkamp EK, Wagenaar J, van
Eden W (2007) Cell stress induced HSP are targets of regulatory
T cells: a role for HSP inducing compounds as anti-inflammatory
immuno-modulators? FEBS Lett 581:3716–3722
Wieten L, van der Zee R, Spiering R, Wagenaar-Hilbers J, van Kooten P,
Broere F, van Eden W (2010) A novel heat-shock protein coinducer
boosts stress protein Hsp70 to activate T cell regulation of inflam-
mation in autoimmune arthritis. Arthritis Rheum 62:1026–1035
Immunological similarity of bacterial and human Hsp40 proteins 659
